No Proof Convalescent Plasma Works Against COVID
September 2, 2020 – There is no evidence to support the use of convalescent plasma to treat patients with COVID-19, and doctors should not consider it a standard of care until after more research is completed, an expert panel from the U.S. National Institutes of Health said Tuesday. .
“There is insufficient data to recommend either for or against the use of convalescent plasma for the treatment of COVID-19,” according to a statement posted on the NIH website by the panel of more than three dozen experts, CNN reported.
“Convalescent plasma should not be considered a standard of care for treating patients with COVID-19,” said the committee, which is evaluating treatments for the new coronavirus.
Convalescent plasma is an antibody-laden serum from the blood of people who have recovered from an infection. The theory is that giving this plasma to new COVID-19 patients will increase their immune response, CNN reported.
Last week, the United States Food and Drug Administration granted emergency use authorization for the use of convalescent plasma for the treatment of COVID-19.
“Prospective, well-controlled and adequately powered randomized trials are needed to determine whether convalescent plasma is effective and safe for the treatment of COVID-19. Members of the public and healthcare providers are encouraged to participate in these prospective clinical trials, ”the panel said.
Our sincere thanks to